Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1972 Dec;51(12):3182–3192. doi: 10.1172/JCI107145

An Analysis of Lipoproteins, Bile Acids, and Red Cell Membranes Associated with Target Cells and Spur Cells in Patients with Liver Disease

Richard A Cooper 1,2,3, Milagros Diloy-Puray 1,2,3, Patricia Lando 1,2,3, Mortimer S Greenberg 1,2,3
PMCID: PMC333000  PMID: 4640953

Abstract

Most patients with stable cirrhosis of the alcoholic have “target” red cells; however, a minority have “spur” cells and severe hemolytic anemia. These two syndromes were studied in 27 patients with target cells and 17 patients with spur cells, all of whom had advanced cirrhosis. The cholesterol and phospholipid content of red cell membranes effectively distinguished target cells from spur cells. Target cells alone were rich in lecithin, and both the cholesterol/phospholipid and cholesterol/lecithin mole ratios were greater in spur cells. The cholesterol/phospholipid mole ratio of both types of red cells correlated closely with the free cholesterol saturation of serum lipoproteins, as defined by the amount of free cholesterol relative to phospholipid and protein in these lipoproteins. Lecithin: cholesterol acyltransferase (LCAT) activity was decreased in most patients with target cells and spur cells; however, the relationship between this activity and the lipid abnormalities observed was weak. Serum bile acid levels also correlated poorly with serum and cell lipids. However, in patients with target cells the amount of cholic and deoxycholic acids in serum was approximately equal to the amount of chenodeoxycholic acid, whereas in patients with spur cells chenodeoxycholic acid (the precursor of lithocholic acid) predominated.

Full text

PDF
3182

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BARTLETT G. R. Phosphorus assay in column chromatography. J Biol Chem. 1959 Mar;234(3):466–468. [PubMed] [Google Scholar]
  2. Balint J. A., Beeler D. A., Kyriakides E. C., Treble D. H. The effect of bile salts upon lecithin synthesis. J Lab Clin Med. 1971 Jan;77(1):122–133. [PubMed] [Google Scholar]
  3. CAREY J. B., Jr The serum trihydroxy-dihydroxy bile acid ratio in liver and biliary tract disease. J Clin Invest. 1958 Nov;37(11):1494–1503. doi: 10.1172/JCI103741. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Calandra S., Martin M. J., McIntyre N. Plasma lecithin: cholesterol acyltransferase activity in liver disease. Eur J Clin Invest. 1971 May;1(5):352–360. doi: 10.1111/j.1365-2362.1971.tb00642.x. [DOI] [PubMed] [Google Scholar]
  5. Carey J. B., Jr, Williams G. Lithocholic acid in human-blood serum. Science. 1965 Oct 29;150(3696):620–622. doi: 10.1126/science.150.3696.620. [DOI] [PubMed] [Google Scholar]
  6. Carey J. B., Jr, Wilson I. D., Zaki F. G., Hanson R. F. The metabolism of bile acids with special reference to liver injury. Medicine (Baltimore) 1966 Nov;45(6):461–470. doi: 10.1097/00005792-196645060-00009. [DOI] [PubMed] [Google Scholar]
  7. Cooper R. A. Anemia with spur cells: a red cell defect acquired in serum and modified in the circulation. J Clin Invest. 1969 Oct;48(10):1820–1831. doi: 10.1172/JCI106148. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Cooper R. A., Garcia F. A., Trey C. X. The effect of lithocholic acid on red cell membranes in vivo. J Lab Clin Med. 1972 Jan;79(1):7–18. [PubMed] [Google Scholar]
  9. Cooper R. A., Gulbrandsen C. L. The relationship between serum lipoproteins and red cell membranes in abetalipoproteinemia: deficiency of lecithin:cholesterol acyltransferase. J Lab Clin Med. 1971 Sep;78(3):323–335. [PubMed] [Google Scholar]
  10. Cooper R. A., Jandl J. H. Bile salts and cholesterol in the pathogenesis of target cells in obstructive jaundice. J Clin Invest. 1968 Apr;47(4):809–822. doi: 10.1172/JCI105775. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Cooper R. A., Jandl J. H. Red cell cholesterol content: a manifestation of the serum affinity for free cholesterol. Trans Assoc Am Physicians. 1969;82:324–330. [PubMed] [Google Scholar]
  12. Cooper R. A., Jandl J. H. The role of membrane lipids in the survival of red cells in hereditary spherocytosis. J Clin Invest. 1969 Apr;48(4):736–744. doi: 10.1172/JCI106031. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Cooper R. A., Jandl J. H. The selective and conjoint loss of red cell lipids. J Clin Invest. 1969 May;48(5):906–914. doi: 10.1172/JCI106049. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Dodge J. T., Cohen G., Kayden H. J., Phillips G. B. Peroxidative hemolysis of red blood cells from patients with abetalipoproteinemia (acanthocytosis). J Clin Invest. 1967 Mar;46(3):357–368. doi: 10.1172/JCI105537. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Eichner E. R., Hillman R. S. The evolution of anemia in alcoholic patients. Am J Med. 1971 Feb;50(2):218–232. doi: 10.1016/0002-9343(71)90151-3. [DOI] [PubMed] [Google Scholar]
  16. GRUNDY S. M., AHRENS E. H., Jr, MIETTINEN T. A. QUANTITATIVE ISOLATION AND GAS--LIQUID CHROMATOGRAPHIC ANALYSIS OF TOTAL FECAL BILE ACIDS. J Lipid Res. 1965 Jul;6:397–410. [PubMed] [Google Scholar]
  17. Gjone E., Norum K. R. Plasma lecithin-cholesterol acyltransferase and erythrocyte lipids in liver disease. Acta Med Scand. 1970 Mar 3;187(3):153–161. doi: 10.1111/j.0954-6820.1970.tb02925.x. [DOI] [PubMed] [Google Scholar]
  18. Gjone E., Orning O. M. Plasma phospholipids in patients with liver disease. A quantitative thin layer chromatographic study. Scand J Clin Lab Invest. 1966;18(2):209–216. doi: 10.3109/00365516609051816. [DOI] [PubMed] [Google Scholar]
  19. Gjone E., Torsvik H., Norum K. R. Familial plasma cholesterol ester deficiency. A study of the erythrocytes. Scand J Clin Lab Invest. 1968;21(4):327–332. doi: 10.3109/00365516809077001. [DOI] [PubMed] [Google Scholar]
  20. Glomset J. A. The plasma lecithins:cholesterol acyltransferase reaction. J Lipid Res. 1968 Mar;9(2):155–167. [PubMed] [Google Scholar]
  21. HAGERMAN J. S., GOULD R. G. The in vitro interchange of cholesterol between plasma and red cells. Proc Soc Exp Biol Med. 1951 Oct;78(1):329–332. doi: 10.3181/00379727-78-19064. [DOI] [PubMed] [Google Scholar]
  22. HAVEL R. J., EDER H. A., BRAGDON J. H. The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J Clin Invest. 1955 Sep;34(9):1345–1353. doi: 10.1172/JCI103182. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. HERBERT V., ZALUSKY R., DAVIDSON C. S. Correlation of folate deficiency with alcoholism and associated macrocytosis, anemia, and liver disease. Ann Intern Med. 1963 Jun;58:977–988. doi: 10.7326/0003-4819-58-6-977. [DOI] [PubMed] [Google Scholar]
  24. HUNT R. D., LEVEILLE G. A., SAUBERLICH H. E. Dietary bile acids and lipid metabolism. II. The ductular cell reaction induced by lithocholic acid. Proc Soc Exp Biol Med. 1963 May;113:139–142. doi: 10.3181/00379727-113-28300. [DOI] [PubMed] [Google Scholar]
  25. Hamnström B., Gjone E., Norum K. R. Familial plasma lecithin: cholesterol acyltransferase deficiency. Br Med J. 1969 May 3;2(5652):283–286. doi: 10.1136/bmj.2.5652.283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. JANDL J. H., LEAR A. A. The metabolism of folic acid in cirrhosis. Ann Intern Med. 1956 Dec;45(6):1027–1044. doi: 10.7326/0003-4819-45-6-1027. [DOI] [PubMed] [Google Scholar]
  27. JANDL J. H. The anemia of liver disease: observations on its mechanism. J Clin Invest. 1955 Mar;34(3):390–404. doi: 10.1172/JCI103087. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Jones D. P., Sosa F. R., Shartsis J., Shah P. T., Skromak E., Beher W. T. Serum cholesterol esterifying and cholesteryl ester hydrolyzing activities in liver diseases: relationships to cholesterol, bilirubin, and bile salt concentrations. J Clin Invest. 1971 Feb;50(2):259–265. doi: 10.1172/JCI106490. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. KAPPAS A., PALMER R. H. Selected aspects of steroid pharmacology. Pharmacol Rev. 1963 Mar;15:123–167. [PubMed] [Google Scholar]
  30. KIMBER C., DELLER D. J., IBBOTSON R. N., LANDER H. THE MECHANISM OF ANAEMIA IN CHRONIC LIVER DISEASE. Q J Med. 1965 Jan;34:33–64. [PubMed] [Google Scholar]
  31. Kilbridge T. M., Heller P. Determinants of erythrocyte size in chronic liver disease. Blood. 1969 Dec;34(6):739–746. [PubMed] [Google Scholar]
  32. Kunz F., Kosin D. Plasma phospholipids in cirrhosis of liver and fatty liver. Clin Chim Acta. 1970 Jan;27(1):185–196. doi: 10.1016/0009-8981(70)90395-5. [DOI] [PubMed] [Google Scholar]
  33. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  34. Makino I., Nakagawa S., Mashimo K. Conjugated and unconjugated serum bile acid levels n patients with hepatobiliary diseases. Gastroenterology. 1969 Jun;56(6):1033–1039. [PubMed] [Google Scholar]
  35. Margolis S., Langdon R. G. Studies on human serum beta-1-lipoprotein. I. Amino acid composition. J Biol Chem. 1966 Jan 25;241(2):469–476. [PubMed] [Google Scholar]
  36. Nair P. P., Garcia C. A modified gas-liquid chromatographic procedure for the rapid determination of bile acids in biological fluids. Anal Biochem. 1969 Apr 11;29(1):164–166. doi: 10.1016/0003-2697(69)90020-7. [DOI] [PubMed] [Google Scholar]
  37. Neerhout R. C. Abnormalities of erythrocyte stromal lipids in hepatic disease. J Lab Clin Med. 1968 Mar;71(3):438–447. [PubMed] [Google Scholar]
  38. Norum K. R., Borsting S., Grundt I. Familial lecithin: cholesterol acyltransferase deficiency. Study of two new patients and their close relatives. Acta Med Scand. 1970 Oct;188(4):323–326. [PubMed] [Google Scholar]
  39. Nye W. H., Marinetti G. V. Alterations in erythrocyte phospholipids produced by environmental change. Proc Soc Exp Biol Med. 1967 Aug-Sep;125(4):1220–1224. doi: 10.3181/00379727-125-32318. [DOI] [PubMed] [Google Scholar]
  40. PHILLIPS G. B. The lipid composition of serum in patients with liver disease. J Clin Invest. 1960 Nov;39:1639–1650. doi: 10.1172/JCI104187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Papadopoulos N. M., Charles M. A. Serum lipoprotein patterns in liver disease. Proc Soc Exp Biol Med. 1970 Jul;134(3):797–799. doi: 10.3181/00379727-134-34886. [DOI] [PubMed] [Google Scholar]
  42. Quarfordt S. H., Hilderman H. L. Quantitation of the in vitro free cholesterol exchange of human red cells and lipoproteins. J Lipid Res. 1970 Nov;11(6):528–535. [PubMed] [Google Scholar]
  43. ROSE H. G., OKLANDER M. IMPROVED PROCEDURE FOR THE EXTRACTION OF LIPIDS FROM HUMAN ERYTHROCYTES. J Lipid Res. 1965 Jul;6:428–431. [PubMed] [Google Scholar]
  44. RUDMAN D., KENDALL F. E. Bile acid content of human serum. I. Serum bile acids in patients with hepatic disease. J Clin Invest. 1957 Apr;36(4):530–537. doi: 10.1172/JCI103450. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Reed C. F. Phospholipid exchange between plasma and erythrocytes in man and the dog. J Clin Invest. 1968 Apr;47(4):749–760. doi: 10.1172/JCI105770. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. SANDBERG D. H., SJOEVALL J., SJOEVALL K., TURNER D. A. MEASUREMENT OF HUMAN SERUM BILE ACIDS BY GAS-LIQUID CHROMATOGRAPHY. J Lipid Res. 1965 Apr;6:182–192. [PubMed] [Google Scholar]
  47. SMITH J. A., LONERGAN E. T., STERLING K. SPUR-CELL ANEMIA: HEMOLYTIC ANEMIA WITH RED CELLS RESEMBLING ACANTHOCYTES IN ALCOHOLIC CIRRHOSIS. N Engl J Med. 1964 Aug 20;271:396–398. doi: 10.1056/NEJM196408202710804. [DOI] [PubMed] [Google Scholar]
  48. SULLIVAN L. W., HERBERT V. SUPPRESSION HEMATOPOIESIS BY ETHANOL. J Clin Invest. 1964 Nov;43:2048–2062. doi: 10.1172/JCI105079. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Sha'afi R. I., Gary-Bobo C., Solomon A. K. Cholesterol effect on hydraulic conductivity of red cell membranes. Biochim Biophys Acta. 1969 Jan 28;173(1):141–142. doi: 10.1016/0005-2736(69)90044-3. [DOI] [PubMed] [Google Scholar]
  50. Shohet S. B., Nathan D. G. Incorporation of phosphatide precursors from serum into erythrocytes. Biochim Biophys Acta. 1970 Feb 10;202(1):202–205. doi: 10.1016/0005-2760(70)90237-7. [DOI] [PubMed] [Google Scholar]
  51. Shohet S. B. Release of phospholipid fatty acid from human erythrocytes. J Clin Invest. 1970 Sep;49(9):1668–1678. doi: 10.1172/JCI106384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Silber R., Amorosi E., Lhowe J., Kayden H. J. Spur-shaped erythrocytes in Laennec's cirrhosis. N Engl J Med. 1966 Sep 22;275(12):639–643. doi: 10.1056/NEJM196609222751204. [DOI] [PubMed] [Google Scholar]
  53. Simon J. B. Red cell lipids in liver disease: relationship to serum lipids and to lecithin-cholesterol acyltransferase. J Lab Clin Med. 1971 Jun;77(6):891–900. [PubMed] [Google Scholar]
  54. Simon J. B., Scheig R. Serum cholesterol esterification in liver disease. N Engl J Med. 1970 Oct 15;283(16):841–846. doi: 10.1056/NEJM197010152831604. [DOI] [PubMed] [Google Scholar]
  55. Skipski V. P., Peterson R. F., Barclay M. Quantitative analysis of phospholipids by thin-layer chromatography. Biochem J. 1964 Feb;90(2):374–378. doi: 10.1042/bj0900374. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Switzer S. Plasma lipoproteins in liver disease. I. Immunologically distinct low-density lipoproteins in patients with biliary obstruction. J Clin Invest. 1967 Nov;46(11):1855–1866. doi: 10.1172/JCI105676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  57. Switzer S. Plasma lipoproteins in the differential diagnosis of liver disease. Gastroenterology. 1967 Nov;53(5):790–793. [PubMed] [Google Scholar]
  58. TURNER K. B., McCORMACK G. H., Jr, RICHARDS A. The cholesterol-esterifying enzyme of human serum. I. In liver disease. J Clin Invest. 1953 Sep;32(9):801–806. doi: 10.1172/JCI102795. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Torsvik H. Presence of (alpha)-1-lipoprotein in patients with familial plasma lecithin: cholesterol acyltransferase deficiency. Scand J Clin Lab Invest. 1969 Sep;24(2):187–196. doi: 10.3109/00365516909080151. [DOI] [PubMed] [Google Scholar]
  60. Weis H. J., Dietschy J. M. Failure of bile acids to control hepatic cholesterogenesis: evidence for endogenous cholesterol feedback. J Clin Invest. 1969 Dec;48(12):2398–2408. doi: 10.1172/JCI106206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  61. Werre J. M., Helleman P. W., Verloop M. C., De Gier J. Causes of macroplania of erythrocytes in diseases of the liver and biliary tract with special reference to leptocytosis. Br J Haematol. 1970 Aug;19(2):223–235. doi: 10.1111/j.1365-2141.1970.tb01618.x. [DOI] [PubMed] [Google Scholar]
  62. ZLATKIS A., ZAK B., BOYLE A. J. A new method for the direct determination of serum cholesterol. J Lab Clin Med. 1953 Mar;41(3):486–492. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES